CAS 677773-91-0

Methyl3-[(6-amino-2-butoxy-7,8-dihydro-8-oxo-9H-purin-9-yl)methyl]benzeneacetate

CAS: 677773-91-0

Formel: C₁₉H₂₃N₅O₄

Reinheit: 98%

Molekulargewicht: 385.4170

Ref: IN-DA01ENLH

Methyl 2-(3-((6-Amino-2-Butoxy-8-Oxo-7,8-Dihydro-9H-Purin-9-Yl)Methyl)Phenyl)Acetate

CAS: 677773-91-0

Methyl 2-(3-((6-Amino-2-Butoxy-8-Oxo-7,8-Dihydro-9H-Purin-9-Yl)Methyl)Phenyl)Acetate

Reinheit: 98%

Molekulargewicht: 385.42g/mol

Ref: 54-OR1023159

SM-324405

CAS: 677773-91-0

SM-324405

Reinheit: ≥95%

Molekulargewicht: 385.42g/mol

Ref: 54-BUP08727

SM-324405

CAS: 677773-91-0

SM-324405 is an agonist of TLR7.

Formel: C₁₉H₂₃N₅O₄

Reinheit: 97.83%

Farbe und Form: Solid

Molekulargewicht: 385.42

Ref: TM-T7860

SM 324405

Kontrolliertes Produkt

CAS: 677773-91-0

Formel: C₁₉H₂₃N₅O₄

Farbe und Form: Neat

Molekulargewicht: 385.417

Ref: TR-S566030

SM 324405

CAS: 677773-91-0

SM 324405 is a long-acting ligand that has been shown to activate the toll-like receptor (TLR) and induce programmed cell death in cancer cells. SM 324405 has been shown to be an inhibitor of PD-L1 and inhibit the proliferation of tumor cells. It is also used as a treatment method for cancer, through immunotherapy, which increases the patient’s immune response to cancer cells. This drug is being studied for its ability to target specific types of cancers, such as melanoma and lung cancer.

Formel: C₁₉H₂₃N₅O₄

Reinheit: Min. 95%

Molekulargewicht: 385.4 g/mol

Ref: 3D-CCB77391